Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson Progress
0% Complete
Diagnostic Assessment and Risk Stratification in Poisoned Patients

Diagnostic Assessment and Risk Stratification in Poisoned Patients

Objective Icon A target symbol, representing a key objective.

Objective

Describe the clinical and diagnostic framework for rapid recognition, laboratory evaluation, and risk stratification of poisoned patients in the ICU.

1. Clinical Toxidromes and Bedside Diagnosis

Rapid identification of a toxidrome—a constellation of signs and symptoms characteristic of a specific class of poison—is the cornerstone of initial management. This allows for empiric therapy while definitive laboratory results are pending.

Key Toxidrome Features

The five classic toxidromes are distinguished by their effects on vital signs, mental status, pupils, and secretions. The table below provides a rapid comparison for bedside differentiation.

Bedside Comparison of Major Toxidromes
Feature Anticholinergic Cholinergic Opioid Sympathomimetic Sedative-Hypnotic
Mental Status Agitated, Delirious Confused, Seizures Depressed, Coma Agitated, Paranoid Depressed, Ataxic
Pupils Mydriasis (dilated) Miosis (constricted) Miosis (constricted) Mydriasis (dilated) Normal or Miosis
Heart Rate Tachycardia Bradycardia Bradycardia Tachycardia Bradycardia/Normal
Skin/Secretions Dry, Flushed, Hot Diaphoretic, Wet Normal Diaphoretic Normal
Mnemonic “Mad as a hatter, blind as a bat, red as a beet, hot as a hare, dry as a bone” “SLUDGE” or “DUMBELS” Classic Triad: CNS depression, miosis, respiratory depression “Fight or flight” Generalized depression
Agents TCAs, Antihistamines Organophosphates Fentanyl, Morphine Cocaine, Amphetamines Benzodiazepines
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: The Great Discriminators

When a patient presents with agitation and tachycardia, the differential narrows to anticholinergic vs. sympathomimetic toxidromes. The fastest way to distinguish them at the bedside is by examining the skin. Sympathomimetic patients are diaphoretic (sweaty), while anticholinergic patients are dry.

Editor’s Note Icon A pencil icon, indicating an editor’s note or a gap in evidence. Editor’s Note: Overlapping Features and Diagnostic Pitfalls

Mixed or polypharmacy overdoses often present with conflicting or atypical features, confounding simple toxidrome classification. For example, co-ingestion of an opioid and a sympathomimetic may result in a normal heart rate. Avoid anchoring bias and be prepared to reassess the diagnosis if the patient does not respond to initial therapies as expected. Insufficient source material exists for a definitive algorithm on managing mixed toxidromes; clinical judgment and frequent reassessment are paramount.

2. Laboratory Diagnostics in Poisoning

Laboratory and imaging data are essential to confirm exposures, quantify the severity of poisoning, identify co-ingestions, and guide targeted therapies like antidotes or extracorporeal removal.

Key Metabolic Markers

Essential Metabolic Calculations in Toxicology
Marker Calculation / Threshold Clinical Significance & Common Causes
Anion Gap Na⁺ – (Cl⁻ + HCO₃⁻)
Normal: ≤12 mmol/L
Elevated gap suggests accumulation of unmeasured anions. A gap >27 mmol/L is highly suggestive of methanol or ethylene glycol poisoning. Other causes include salicylates, metformin (lactic acidosis), and uremia.
Osmolal Gap Measured Osm – Calculated Osm
Normal: <10 mOsm/kg
Elevated gap indicates the presence of osmotically active, low-molecular-weight substances. Primarily used to screen for toxic alcohols (methanol, ethylene glycol, isopropanol).
Lactate >2 mmol/L (concerning)
>4 mmol/L (severe)
Marker of tissue hypoperfusion (shock) or direct mitochondrial toxicity. Key causes include cyanide, carbon monoxide, metformin, and severe sympathomimetic or salicylate poisoning.
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Mind Both Gaps

When toxic alcohol ingestion is suspected, always calculate both the anion and osmolal gaps. Initially, the parent alcohol (e.g., methanol) causes a high osmolal gap but no anion gap. As it is metabolized to toxic acids (e.g., formic acid), the osmolal gap decreases while the anion gap rises. A patient can present anywhere along this timeline.

Serum Toxin Levels & Specialized Tests

  • Quantitative Levels: Specific levels are crucial for agents with nomogram-based treatments (acetaminophen) or where levels correlate with severity and guide therapy (salicylates, digoxin, lithium).
  • Co-oximetry: A specialized blood gas analysis that directly measures carboxyhemoglobin and methemoglobin levels, which is essential for diagnosing carbon monoxide poisoning and methemoglobinemia, respectively. Standard pulse oximetry is unreliable in these conditions.
  • Toxicology Screens: Rapid urine immunoassays are often used for initial screening but have significant limitations, including false positives and false negatives. They should not be used to rule out exposure, and confirmatory testing (e.g., GC-MS) is often required.

3. Severity Scoring and Risk Stratification

Standardized scoring systems help to objectively assess the severity of poisoning, facilitate clear communication, guide the appropriate level of care, and track the patient’s clinical trajectory.

Poisoning Severity Score (PSS)

The PSS is a simple, widely used tool to grade the overall severity of a poisoning case.

  • 0 None: No symptoms or signs related to poisoning.
  • 1 Mild: Mild, transient, and spontaneously resolving symptoms.
  • 2 Moderate: Pronounced or prolonged symptoms requiring medical intervention.
  • 3 Severe: Severe or life-threatening symptoms.
  • 4 Fatal: Death resulting from poisoning.

Glasgow Coma Scale (GCS) and ICU Scores

  • Glasgow Coma Scale (GCS): A fundamental tool for assessing level of consciousness. A score of GCS ≤ 8 is a critical threshold often indicating the need for definitive airway protection (intubation).
  • General ICU Scores (APACHE II, SAPS II): While these scores can estimate overall mortality risk in critically ill patients, they are not specifically validated for poisoned patients and may not accurately reflect risks associated with specific toxins.
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl: Use Trends, Not Snapshots

A single severity score is a snapshot in time. The true value of these tools lies in serial assessments. A declining GCS or an increasing PSS is a red flag that signals clinical deterioration and the need to escalate care, even if the initial score was not in a critical range.

4. Clinical Decision Algorithms

Effective management of the poisoned patient requires a systematic approach that integrates bedside findings, laboratory data, and risk scores into a cohesive management plan.

Toxicology Patient Management Algorithm A flowchart showing the management pathway for a poisoned patient, starting with ABC stabilization, moving to bedside toxidrome assessment and lab diagnostics, then to risk stratification using scores, and finally to a decision on the level of care and specific treatments. Step 1: Stabilize Airway, Breathing, Circulation Step 2a: Bedside Assessment History, Vitals, Exam Identify Toxidrome Step 2b: Diagnostic Data Labs (Gaps, Levels) ECG, Imaging Step 3: Risk Stratify Calculate PSS & GCS Step 4: Intervene Supportive Care, Antidotes, Triage
Figure 1: Integrated Management Pathway for the Poisoned Patient. This algorithm emphasizes the parallel processes of clinical assessment and diagnostic evaluation, which converge for risk stratification and guide the final decisions on intervention and level of care.

Linking Scores to Triage and Care Levels

  • Low Risk (e.g., PSS 0-1, GCS 15, asymptomatic): Can often be managed with observation on a medical floor. Requires serial exams to ensure no delayed toxicity.
  • Moderate Risk (e.g., PSS 2, GCS 9-14, mild symptoms): Warrants admission to an intermediate care or step-down unit with continuous cardiac and pulse oximetry monitoring.
  • High Risk (e.g., PSS ≥3, GCS ≤8, critical lab values, hemodynamic instability): Requires immediate ICU admission for invasive monitoring, potential airway protection, and administration of antidotes or consideration for extracorporeal toxin removal.

References

  1. Emergency Care BC. Common toxidromes – diagnosis & treatment. Emergency Care BC Clinical Resource. 2018.
  2. Royal College of Emergency Medicine. Management of Patients with Suspected but Unidentified Poisoning in the Emergency Department. RCEM; 2025.
  3. Hovda KE, Hunderi OH, Rudberg N, et al. Anion and osmolal gaps in the diagnosis of methanol poisoning. Intensive Care Med. 2004;30(9):1842–1846.
  4. Marts LT. Mind the Gap. Ann Am Thorac Soc. 2014;11(5):701–704.